California’s Osseon Therapeutics Received FDA Allowance for VCF Compression Technology

Osseon Therapeutics, a Santa Rosa, Calif.-based biomedical device company, received the FDA notice of allowance for its spinal vertebral compression technology as part of its Osseoplasty systems, according to a company news release.

Advertisement

The first generation of Osseoplasty was approved in 2009 and Osseon has upgraded the system with VCF technology.

Read the news release on spinal vertebral compression technology.

Read more coverage on VCF technology:

– RF Kyphoplasty Shows Less Cement Leakage Than Vertebroplasty

– Stryker Interventional Spine Launches iVAS Inflatable Vertebral Augmentation System

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • Since March 25, there have been two key developments in lawsuits involving spine medtech companies. 1. The U.S. Court of…

  • The highest-paid CFOs at spine and orthopedic medtech companies saw total compensation reaching in the mid-single digits and beyond. Here…

Advertisement

Comments are closed.